Orexigen Therapeutics to Present at Upcoming Conferences

SAN DIEGO, May 8, 2012 /PRNewswire/ -- Orexigen® Therapeutics, Inc. (Nasdaq: OREX) today announced that management will be presenting at two upcoming investor conferences. The details are as follows:

The 11th Annual JMP Securities Research Conference
Date: May 15, 2012
Time: 4:00pm Pacific Time
Location: Ritz-Carlton, San Francisco
Speaker: Michael Narachi, President and Chief Executive Officer

Bank of America Merrill Lynch 2012 Health Care Conference
Date: May 17, 2012
Time: 10:40am Pacific Time
Location: Encore at Wynn Las Vegas
Speaker: Michael Narachi, President and Chief Executive Officer

To listen to the live webcast or a replay of the presentations, please visit the Investor Relations section of the company's Web site at www.orexigen.com. A replay will be available for 14 days after the event.

About Orexigen® Therapeutics
Orexigen Therapeutics, Inc. is a biopharmaceutical company focused on the treatment of obesity. The Company's lead product candidate is Contrave®, which has completed Phase III clinical trials and for which a New Drug Application has been submitted and reviewed by the FDA. The Company has also reached agreement with the FDA on a Special Protocol Assessment for the Contrave cardiovascular outcomes trial which the company plans to initiate this quarter. The Company's other product candidate, Empatic™, has completed Phase II clinical trials. Further information about the Company can be found at www.orexigen.com.

Orexigen Contact:

Media Contact:       

McDavid Stilwell

Denise Powell

VP, Corporate Communications and Business Development


(858) 875-8629

(510) 703-9491

SOURCE Orexigen Therapeutics, Inc.


More by this Source

Custom Packages

Browse our custom packages or build your own to meet your unique communications needs.

Start today.


PR Newswire Membership

Fill out a PR Newswire membership form or contact us at (888) 776-0942.

Learn about PR Newswire services

Request more information about PR Newswire products and services or call us at (888) 776-0942.